Nov 15-19, 2014
Join or renew your AHA/ASA Professional Membership today to save on registration
for all AHA Scientific Sessions.
Registration opens in June!
Saturday, Nov. 15, 2014
8:00 a.m. – 5:00 p.m.
Location – TBD
Registration -- Opens June 11, 2014
This workshop is designed to enable vascular and cardiovascular post-graduate trainees and junior faculty to more effectively identify and treat peripheral vascular disorders and, by so doing, reduce death and disability from arteriosclerosis and venous thrombosis. The workshop brings together trainees from diverse disciplines, including cardiovascular and vascular medicine, vascular surgery, and interventional cardiology and interventional radiology to facilitate discussion of the common evidence base practices. It also fosters the commitment of participants to the lifelong creation of cooperative and mutually supportive clinical environments, thus promoting the use of cost-effective, evidence-based diagnostic and therapeutic management strategies for patients with peripheral vascular disorders.
After participating in this activity, participants should be able to:
- Describe the epidemiology of PAD and effective approaches to its diagnosis and management.
- Explain outcomes from the CLEVER and ERASE trials and their potential ramifications for PAD treatment.
- Recognize gender differences in the prevalence, risk factors, presentation, and outcomes of PAD and effectively manage and treat women with PAD.
- Implement evidence-based recommendations to prevent secondary cardiovascular events in patients with PAD.
- Define clinical manifestations of CLI and current approaches to risk stratification and treatment.
- Explain results from studies comparing EVAR with open repair for AAA and their implications for patient selection and management.
- Explain the risks and benefits of endovascular versus medical approaches for treatment of RAS.
- Discuss the risks and benefits of medical therapy versus interventional approaches in patients with carotid artery disease.
- Describe current best practices, controversies, new clinical evidence, and ongoing trials in the area of thrombolytic therapy for the treatment of VTE.
- Describe the potential risks and benefits of available and emerging novel and anticoagulants for the prophylaxis and treatment of VTE.
Sponsored by the Council on Peripheral Vascular Disease (PVD), the PVD Fellows in Training Workshop is a unique multidisciplinary educational event with topics presented by leaders in the field of peripheral arterial disease. This workshop exposes healthcare providers to the most recent PAD updates and provides guidance to a successful career. The Mentorship Feast scheduled at noon is an unprecedented, exclusive mentoring opportunity for attendees to informally talk and network with leaders from the PVD Council.
View the PVD FIT Workshop preliminary program (PDF) and make sure you join us on Saturday, Nov. 15!